Status:
COMPLETED
Measuring Alterations of DNA in Human Blood
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Litron Laboratories
Conditions:
Neoplasms
Eligibility:
All Genders
21-70 years
Brief Summary
The purpose of this research is to evaluate an automated, laser-based technique for measuring DNA damge resulting from radiation. We want to use controlled exposure on cancer patients to help develop ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or female, age 21 to 70 years old.
- Patient undergoing with anti-neoplastic agent(s) known to have genotoxic activity (e.g., cyclophosphamide, 5-FU, cisplatin, Ara-C.
- X-irradiation may be considered, so long as a substantial fraction of red marrow is exposed (e.g., femur or chest/trunk region);
- treatment could be ongoing therapy or initial therapy.
Exclusion
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00178308
Last Update
September 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States